Learn more

STERRENBELD BIOTECHNOLOGIE NORTH AMERICA INC

Overview
  • Total Patents
    75
  • GoodIP Patent Rank
    204,899
  • Filing trend
    0.0%
About

STERRENBELD BIOTECHNOLOGIE NORTH AMERICA INC has a total of 75 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1996. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are BRESATEC LTD, BIOAGRI CORP and DNX BIOTHERAPEUTICS INC.

Patent filings per year

Chart showing STERRENBELD BIOTECHNOLOGIE NORTH AMERICA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Melo Carlos 30
#2 Criscuolo Marcelo 30
#3 Melo Carlos Alberto 27
#4 Carcagno Carlos Miguel 20
#5 Vidal Juan Alejandro 17
#6 Baranao Lino 16
#7 Prync Aida 14
#8 Bercovich Andres 14
#9 Fernandez Nahuel 14
#10 Criscuolo Marcelo Eduardo 9

Latest patents

Publication Filing date Title
CA2690564A1 Transgenic mammals that produce exogenous proteins in milk
BRPI0811386A2 "plasmid, method for transfection of plasmid, non-human transgenic mammal, non-human transgenic bovine mammer producing a modified human insulin cursor and a non-human producing murgine
BRPI0415147A method for producing a protein, method for purifying a recombinant growth hormone from the milk of a non-human transgenic mammal producing a recombinant growth hormone, and method for purifying a recombinant growth hormone from the milk of a non-mammal a transgenic protein that produces a recombinant growth hormone
CN101413003A Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
BRPI0401635A Compound
EP2308502A1 Method to induce neovascular formation and tissue regeneration
WO03035669A1 Amphiphilic cationic lipids derived from cholesterol
WO0027419A1 Method for obtaining lyophilized pharmaceutical compositions of recombinant human erythropoietin stable at room temperature
US6777205B1 Host cells expressing recombinant human erythropoietin
WO0068253A1 Dna promoter sequence for gene expression
BR9917348A Procedure to prepare 2-chloro-2'-deoxyadenosine (claradribine) and its 3,5-di-p-o-toluyl derivative
WO0064918A1 METHOD FOR THE PRODUCTION OF 2-CHLORO-2'-DEOXYADENOSINE (CLADRIBINE) AND ITS 3,5-DI-O-p-TOLUOYL DERIVATIVE